Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy

Abstract

These findings suggest that combination antiretroviral regimens suppress HIV-1 replication in some but not all patients. Given the half-life of latently infected CD4 lymphocytes of about six months, it may require many years of effective antiretroviral treatment to eliminate this reservoir of HIV-1.